Stained at Biology Products
Stained at Biology Technology
Stained at Medicine News
New Study Suggests Special Cocoa may Lead to Sustained Improvement in Blood Vessel Function
Drinking a specially-made cocoa beverage daily may have the potential to reverse impairments in the functioning of blood vessels//, according to a first-of-its-kind study published in the Journal of Cardiovascular Pharmacology. The cocoa used in the study was rich in flavanols, naturally-occurring compounds abundant in freshly harvested cocoa prior to their destruction during the typical...
Maninder Says Wrist Injuries Were Sustained Accidentally
Former cricketer Maninder Singh, who was admitted to a hospital in East Delhi after he su
stained injuries on his wrist on Saturday raising speculations of a suicide attempt by him, today said he su
stained injuries accidentally. In a statement to the Delhi Police, Singh said that he had injured his wrist when the glass window panes broke when he banged his hands on them to wake his...
Stained at Medicine Products
Stained at Medicine Technology
A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to
Sustained Reductions in Blood Glucose Levels for 6 Months
Post-treatment in Type 2 Diabetes Patients
Final Results from Exploratory Phase IIa Clinical Trial in Type 2Diabetes Patients Announced TORONTO, June 28, 2007 /PRNewswire-FirstCall/ - TransitionTherapeutics Inc. ("Transition") , today announces the results fromits exploratory Phase IIa clinical trial indicating that 4-weeks ofdaily treatments with gastrin-based therapy, E1-I.N.T.(TM), showedsu
stained reductions in blood glucose co...
OREXIGEN Therapeutics Announces Sustained-Release Formulation of
Zonisamide Shows Improved Tolerability When Compared to Immediate
Release Formulation
Orexigen(TM) is evaluating zonisamide SR as a novel component inEMPATIC(TM) Phase IIb obesity trial SAN DIEGO, June 07, 2007 /PRNewswire-FirstCall/ -- Orexigen(TM)Therapeutics, Inc. , a biopharmaceutical company focused on thetreatment of central nervous system disorders with an initial focuson obesity, today announced results from a Phase I trial evaluatingsafety and pharmacokinetics of...
Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides
Sustained Immune Response in 100 Percent of Women up to 55 Years of
Age
New Study Results Show Antibodies Against Cancer-Causing VirusTypes 16 & 18 That Are At Least Ten Times Greater Than NaturalInfection Levels CHICAGO, June 05, 2007 /PRNewswire/ -- New Phase III data showthat at 18 months after the first of a three-dose regimen, 100percent of women up to age 55 vaccinated with the GlaxoSmithKline(GSK) cervical cancer candidate vaccine had antibodies pr...
Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III
Melanoma Demonstrated Significant and Sustained Impact on
Relapse-Free Survival
CHICAGO – June 2, 2007 – Long-term treatment withpegylated interferon alfa-2b in stage III melanoma had asignificant and su
stained impact on relapse-free survival (RFS),according to the results of the largest adjuvant trial everconducted in patients with stage III melanoma. Results of the PhaseIII study, led by...
Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing
Sustained Safety and Significant Reductions in Repeat Procedures
BARCELONA, Spain--(BUSINESS WIRE)--May 22, 2007 - Medtronic(NYSE:MDT) today presented new long-term data from the ENDEAVORclinical trial program reinforcing the existing safety and efficacyprofile of the Endeavor(R) drug-eluting coronary stent system.Four-year results from the 100-patient first-in-man ENDEAVOR Itrial and three-year results from the nearly 1,200 patient ENDEAVORII trial demo...
More>>